Picture of Life Science Reit logo

LABS Life Science Reit News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsAdventurousSmall CapMomentum Trap

Life Science REIT Morgan Stanley - Holding(s) in Company

RNS Number : 1358Z

Life Science REIT PLC

01 April 2026

 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BP5X4Q29

Issuer Name

LIFE SCIENCE REIT PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Morgan Stanley

City of registered office (if applicable)

 

Country of registered office (if applicable)

US

NameCity of registered officeCountry of registered office
Morgan StanleyWilmington, DelawareUSA
4. Details of the shareholder
NameCity of registered officeCountry of registered office
Morgan Stanley & Co. International plcLondonUNITED KINGDOM
5. Date on which the threshold was crossed or reached 30-Mar-2026 6. Date on which Issuer notified 01-Apr-2026 7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A)% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)Total of both in % (8.A + 8.B)Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached9.0943670.0000009.09436731830285
Position of previous notification (if applicable)8.0150010.0002388.015239
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached 8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible)Number of direct voting rights (DTR5.1)Number of indirect voting rights (DTR5.2.1)% of direct voting rights (DTR5.1)% of indirect voting rights (DTR5.2.1)
GB00BP5X4Q29318302859.094367
Sub Total 8.A318302859.094367%
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrumentExpiration dateExercise/conversion periodNumber of voting rights that may be acquired if the instrument is exercised/converted% of voting rights
Sub Total 8.B1
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial instrumentExpiration dateExercise/conversion periodPhysical or cash settlementNumber of voting rights% of voting rights
Sub Total 8.B2
9. Information in relation to the person subject to the notification obligation 2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
Ultimate controlling personName of controlled undertaking% of voting rights if it equals or is higher than the notifiable threshold% of voting rights through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable threshold
Morgan Stanley (Chain 1)
Morgan Stanley (Chain 1)Morgan Stanley International Holdings Inc.
Morgan Stanley (Chain 1)Morgan Stanley International Limited
Morgan Stanley (Chain 1)Morgan Stanley Investments (UK)
Morgan Stanley (Chain 1)Morgan Stanley & Co. International plc9.0943679.094367%
10. In case of proxy voting Name of the proxy holder   The number and % of voting rights held   The date until which the voting rights will be held   11. Additional Information   12. Date of Completion 01-Apr-2026 13. Place Of Completion Glasgow This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END     HOLUPUCACUPQGAG

Recent news on Life Science Reit

See all news